# Novanta Inc. – Consensus ‘buy’ rating and -2.5% Downside Potential

- Link: https://www.directorstalkinterviews.com/novanta-inc.consensus-buy-rating-and-2.5-downside-potential/4121136260
- Published: 2023-12-15T12:43:56+00:00
- Author: Charlotte Edwards

**Novanta Inc.** with ticker code (NOVT) now have 2 analysts in total covering the
stock. The consensus rating is pointing to ‘buy’. The range between the high target
price and low target price is between $162.00 and $150.00 calculating the mean target
price we have $156.00. Given that the stocks previous close was at $159.94 this 
now indicates there is a potential downside of -2.5%. The 50 day MA is $140.95 and
the 200 day MA is $155.88. The market cap for the company is 5.98B. The stock price
for the company is currently $166.96 USD

 The potential market cap would be $5,831,618,819 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 79.89, revenue per share of $24.81
and a 6.56% return on assets.

Novanta Inc. is a global supplier of core technology solutions to medical and advanced
industrial original equipment manufacturers. Its segments include Photonics, Vision,
and Precision Motion. The Photonics segment designs, manufactures and markets photonics-
based solutions, including laser scanning, laser beam delivery, carbon dioxide (
CO2) laser, solid state laser, ultrafast laser, and optical light engine products
to customers worldwide. The Vision segment designs, manufactures and markets a range
of medical grade technologies, including medical insufflators, pumps and related
disposables; visualization solutions; wireless technologies, video recorder and 
video integration technologies. The Precision Motion segment designs, manufactures
and markets optical and inductive encoders, precision motors, servo drives and motion
control solutions, integrated stepper motors, intelligent robotic end-of-arm technology
solutions, air bearings, and air bearing spindles to customers worldwide.

Share on:
